A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from the processing of autologous human somatic stem cells()

To make sure that novel human cell-based products contribute to human health care, it is essential that, based on sound science at present, suitable measures be taken by the manufacturers and regulatory authorities on applying these products to the treatment of patients by taking into account specif...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Regen Ther
Päätekijät: Hayakawa, Takao, Aoi, Takashi, Umezawa, Akihiro, Ozawa, Keiya, Sato, Yoji, Sawa, Yoshiki, Matsuyama, Akifumi, Yamanaka, Shinya, Yamato, Masayuki
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Japanese Society for Regenerative Medicine 2015
Aiheet:
Special Article: Regulatory science
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6581870/
https://ncbi.nlm.nih.gov/pubmed/31245460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.reth.2015.05.002
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia